These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 30452915)

  • 21. Providing data for serrated polyp detection rate benchmarks: an analysis of the New Hampshire Colonoscopy Registry.
    Anderson JC; Butterly LF; Weiss JE; Robinson CM
    Gastrointest Endosc; 2017 Jun; 85(6):1188-1194. PubMed ID: 28153571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fecal immunochemical test in cancer screening - colonoscopy outcome in FIT positives and negatives.
    Ribbing Wilén H; Blom J; Höijer J; Andersson G; Löwbeer C; Hultcrantz R
    Scand J Gastroenterol; 2019 Mar; 54(3):303-310. PubMed ID: 30907196
    [No Abstract]   [Full Text] [Related]  

  • 23. Impact of Fellow Participation During Colonoscopy on Adenoma Detection Rates.
    Araujo JL; Jaiswal P; Ragunathan K; Arroyo-Mercado FM; Chawla GS; Li C; Kazmi W; Le A; Gupta N; Chokshi T; Klinger CA; Salim S; Mirza RM; Grossman E; Vignesh S
    Dig Dis Sci; 2022 Jan; 67(1):85-92. PubMed ID: 33611689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does Low Threshold Value Use Improve Proximal Neoplasia Detection by Fecal Immunochemical Test?
    Kim NH; Yang HJ; Park SK; Park JH; Park DI; Sohn CI; Choi K; Jung YS
    Dig Dis Sci; 2016 Sep; 61(9):2685-93. PubMed ID: 27107865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proposal of high-risk adenoma detection rate as an impactful, complementary quality indicator of colonoscopy.
    Wadhwa V; Jobanputra Y; Al Taii H; Thota PN; Lopez R; Gurudu SR; Sanaka MR
    Surg Endosc; 2020 Jan; 34(1):325-331. PubMed ID: 30927122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenoma Detection Rate in Colonoscopy: Is Indication a Predictor?
    Yang PF; Wong SW
    Surg Laparosc Endosc Percutan Tech; 2016 Apr; 26(2):156-61. PubMed ID: 26813239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The conversion factor for predicting adenoma detection rate from polyp detection rate varies according to colonoscopy indication and patient sex.
    Vojtechova G; Ngo O; Grega T; Kmochova K; Voska M; Buckova B; Majek O; Zavoral M; Suchanek S
    Eur J Cancer Prev; 2020 Jul; 29(4):294-302. PubMed ID: 32543806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Quality Measures for Detection of Neoplasia at Screening Colonoscopy.
    Wieszczy P; Bugajski M; Januszewicz W; Rupinska M; Szlak J; Pisera M; Turkot MH; Rupinski M; Wojciechowska U; Didkowska J; Regula J; Kaminski MF
    Clin Gastroenterol Hepatol; 2023 Jan; 21(1):200-209.e6. PubMed ID: 35341951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of a higher fecal immunochemistry test cut-off on pathology detected in subsequent rounds of a colorectal screening program.
    Gibson DJ; Mooney T; Mooney J; Mulcahy HE; O'Donoghue D
    Gastrointest Endosc; 2019 Mar; 89(3):518-522. PubMed ID: 30142350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in detection rates of adenomas and serrated polyps in screening versus surveillance colonoscopies, based on the new hampshire colonoscopy registry.
    Anderson JC; Butterly LF; Goodrich M; Robinson CM; Weiss JE
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1308-12. PubMed ID: 23660415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Higher risk of advanced histology in adenoma less than 10 mm in fecal immunochemical test screening: Implication for management.
    Hsu WF; Cheng SY; Shun CT; Chang LC; Tu CH; Wang HP; Wu MS; Chiu HM
    J Gastroenterol Hepatol; 2020 Oct; 35(10):1738-1745. PubMed ID: 32187748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of adenomas per colonoscopy and adenomas per positive participant as new quality parameters in screening colonoscopy.
    Gessl I; Waldmann E; Penz D; Majcher B; Dokladanska A; Hinterberger A; Szymanska A; Ferlitsch A; Trauner M; Ferlitsch M
    Gastrointest Endosc; 2019 Mar; 89(3):496-502. PubMed ID: 30138613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of a computer-aided detection system in a fecal immunochemical test-based organized colorectal cancer screening program: a randomized controlled trial (AIFIT study).
    Rondonotti E; Di Paolo D; Rizzotto ER; Alvisi C; Buscarini E; Spadaccini M; Tamanini G; Paggi S; Amato A; Scardino G; Romeo S; Alicante S; Ancona F; Guido E; Marzo V; Chicco F; Agazzi S; Rosa C; Correale L; Repici A; Hassan C; Radaelli F;
    Endoscopy; 2022 Dec; 54(12):1171-1179. PubMed ID: 35545122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Efficacy comparison among high risk factors questionnaire and Asia-Pacific colorectal screening score and their combinations with fecal immunochemical test in screening advanced colorectal tumor].
    Zhu N; Huang YQ; Song YM; Zhang SZ; Zheng S; Yuan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jul; 25(7):612-620. PubMed ID: 35844124
    [No Abstract]   [Full Text] [Related]  

  • 35. Difference in Physician- and Patient-Dependent Factors Contributing to Adenoma Detection Rate and Serrated Polyp Detection Rate.
    Cavicchi M; Tharsis G; Burtin P; Cattan P; Venezia F; Tordjman G; Gillet A; Samama J; Nahon-Uzan K; Karsenti D
    Dig Dis Sci; 2019 Dec; 64(12):3579-3588. PubMed ID: 31471862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An Adjusted Level of Adenoma Detection Rate is Necessary for Adults Below 50 Years Old.
    Yoon JY; Cha JM; Shin JE; Kim KO; Yang HJ; Kim HG; Cho YS; Boo SJ; Lee J; Jung Y; Lee HJ; Koo HS; Joo YE;
    J Clin Gastroenterol; 2018 Sep; 52(8):703-708. PubMed ID: 28787362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenoma Detection Rate and Colorectal Cancer Risk in Fecal Immunochemical Test Screening Programs : An Observational Cohort Study.
    Zorzi M; Antonelli G; Barbiellini Amidei C; Battagello J; Germanà B; Valiante F; Benvenuti S; Tringali A; Bortoluzzi F; Cervellin E; Giacomin D; Meggiato T; Rosa-Rizzotto E; Fregonese D; Dinca M; Baldassarre G; Scalon P; Pantalena M; Milan L; Bulighin G; Di Piramo D; Azzurro M; Gabbrielli A; Repici A; Rex DK; Rugge M; Hassan C; ; Giacomin A; Buda A; Costa D; Checchin D; Marin R; Patarnello E; Ceriani A; Guido E; Bertomoro P; Merlini N; Murer F; Ntakirutimana E; Benazzato L; Bellocchi MCC
    Ann Intern Med; 2023 Mar; 176(3):303-310. PubMed ID: 36802754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Data quality and colonoscopy performance indicators in the prevalent round of a FIT-based colorectal cancer screening program.
    Lund M; Erichsen R; Valori R; Møller Jensen T; Helle Njor S; Laurberg S; Andersen B;
    Scand J Gastroenterol; 2019 Apr; 54(4):471-477. PubMed ID: 30978128
    [No Abstract]   [Full Text] [Related]  

  • 39. Fecal Immunochemical Test Detects Sessile Serrated Adenomas and Polyps With a Low Level of Sensitivity.
    Chang LC; Shun CT; Hsu WF; Tu CH; Tsai PY; Lin BR; Liang JT; Wu MS; Chiu HM
    Clin Gastroenterol Hepatol; 2017 Jun; 15(6):872-879.e1. PubMed ID: 27498176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenoma detection by Endocuff-assisted versus standard colonoscopy in an organized screening program: the "ItaVision" randomized controlled trial.
    Zorzi M; Hassan C; Battagello J; Antonelli G; Pantalena M; Bulighin G; Alicante S; Meggiato T; Rosa-Rizzotto E; Iacopini F; Luigiano C; Monica F; Arrigoni A; Germanà B; Valiante F; Mallardi B; Senore C; Grazzini G; Mantellini P;
    Endoscopy; 2022 Feb; 54(2):138-147. PubMed ID: 33524994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.